Advertisement
Home Blog Page 3605
The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain advanced or unresectable soft-tissue sarcomas.

FDA Approves Yondelis for Soft-Tissue Sarcoma

0
Drug sanctioned for liposarcoma or leiomyosarcoma
Paintball

AAP: Paintball, BB Guns Can Severely Injure Children

0
Serious eye injuries, organ damage can occur, researchers warn
Therapy dogs appear to provide children being treated for cancer with both physical and mental benefits

AAP: Dogs Help Curb Anxiety in Children With Cancer

0
'Therapy dogs' appear to ease heart rate, lower blood pressure in children fighting the disease

American Society for Radiation Oncology, Oct. 18-21

0
The 57th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology (ASTRO) was...
Most cow's milk allergic patients undergoing oral immunotherapy are able to consume cow's milk protein regularly without significant adverse reactions

Oral Immunotherapy Seems Beneficial for Cow’s Milk Allergy

0
Most patients are able to consume cow's milk protein regularly without serious adverse effects
Eight reasons associated with patient's intentional nonadherence to medications have been identified in a report published by the American Medical Association.

AMA: Eight Reasons for Nonadherence to Medications

0
Reasons include fear of side effects, costs, misunderstanding of the need for medications
Operative vaginal delivery remains an important component of modern labor management

ACOG: Operative Vaginal Delivery Remains Appropriate

0
Operative vaginal delivery accounted for 3.3 percent of all deliveries in 2013
Lower-level radiation and chemotherapy may be as effective as standard doses for some patients with human papillomavirus-related oropharyngeal squamous cell carcinoma

ASTRO: Less Treatment Effective in HPV-Related Oropharynx CA

0
Lower doses of chemotherapy, radiation may also reduce unwanted side effects
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) to be used in combination with fluorouracil and leucovorin in advanced pancreatic cancer.

FDA Approves Onivyde for Metastatic Pancreatic Cancer

0
To be used in combination with fluorouracil/leucovorin for advanced disease
Repeated antibiotic use is linked to greater weight gains in children

Childhood Antibiotics Rx Tied to Weight Gain Through Adolescence

0
Study finds link between repeated use in children and slightly higher weights in teen years